Literature DB >> 27448414

Upper Airway Collapsibility Assessed by Negative Expiratory Pressure while Awake is Associated with Upper Airway Anatomy.

Raquel P Hirata1, Fabiola Schorr1, Fabiane Kayamori1, Henrique Takachi Moriya2, Salvatore Romano3, Giuseppe Insalaco3, Eloisa M Gebrim4, Luis Vicente Franco de Oliveira5, Pedro R Genta1, Geraldo Lorenzi-Filho1.   

Abstract

STUDY
OBJECTIVES: There is a growing interest to develop a simple method to characterize the mechanisms leading to upper airway collapse in order to guide treatment options in patients with obstructive sleep apnea (OSA). Critical closing pressure (Pcrit) during sleep is able to predict the anatomical component of OSA. However, Pcrit is a laborious method that is only used for research purposes. The application of negative expiratory pressure (NEP) is a simple method to assess upper airway collapsibility that can be easily performed during wakefulness. We hypothesized that NEP will be, similarly to Pcrit, associated with upper airway anatomy assessed by computed tomography (CT) scan.
METHODS: Patients under investigation for OSA underwent polysomnography, CT of the upper airway, NEP while awake, and Pcrit during sleep. NEP was performed with -5 cm H2O in supine position using a nasal mask. Pcrit was measured during sleep induced by low doses of midazolam.
RESULTS: Twenty-eight male subjects were studied (age 45 ± 13 y, body mass index 29.4 ± 4.9 kg/m2, apnea-hypopnea index (AHI) 30 ± 26, range 2 to 86 events/h). NEP and Pcrit were similarly associated with tongue area (r = 0.646 and r = 0.585), tongue volume (r = 0.565 and r = 0.613) and pharyngeal length (r = 0.580 and r = 0.611), respectively (p < 0.05 for all comparisons). NEP and Pcrit were also significantly correlated with AHI (r = 0.490 and r = 0.531). NEP and Pcrit were significantly higher in patients with severe OSA than the remaining population.
CONCLUSIONS: NEP is a simple and promising method that is associated with the anatomical component of upper airway collapsibility. NEP may be valuable to select patients for noncontinuous positive airway pressure alternative therapies for OSA.
© 2016 American Academy of Sleep Medicine

Entities:  

Keywords:  anatomy; computed tomography; obstructive sleep apnea; pathophysiology; pharynx

Mesh:

Year:  2016        PMID: 27448414      PMCID: PMC5033735          DOI: 10.5664/jcsm.6184

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  37 in total

1.  Effect of negative expiratory pressure on respiratory system flow resistance in awake snorers and nonsnorers.

Authors:  C Tantucci; A Duguet; A Ferretti; S Mehiri; I Arnulf; M Zelter; T Similowski; J P Derenne; J Milic-Emili
Journal:  J Appl Physiol (1985)       Date:  1999-09

Review 2.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

Review 3.  A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions.

Authors:  Amy M Sawyer; Nalaka S Gooneratne; Carole L Marcus; Dafna Ofer; Kathy C Richards; Terri E Weaver
Journal:  Sleep Med Rev       Date:  2011-06-08       Impact factor: 11.609

4.  Detection of expiratory flow limitation during mechanical ventilation.

Authors:  P Valta; C Corbeil; A Lavoie; R Campodonico; N Koulouris; M Chassé; J Braidy; J Milic-Emili
Journal:  Am J Respir Crit Care Med       Date:  1994-11       Impact factor: 21.405

5.  Expiratory flow limitation in awake sleep-disordered breathing subjects.

Authors:  G Liistro; C Veriter; M Dury; G Aubert; D Stanescu
Journal:  Eur Respir J       Date:  1999-07       Impact factor: 16.671

6.  Influence of upper airway size on volume exhaled under negative pressure during evaluation of upper airway collapsibility.

Authors:  Luigi Taranto Montemurro; Michela Bettinzoli; Luciano Corda; Stefania Redolfi; Mauro Novali; Alessia Braghini; Claudio Tantucci
Journal:  Sleep Breath       Date:  2011-03-23       Impact factor: 2.816

7.  A new method of negative expiratory pressure test analysis detecting upper airway flow limitation to reveal obstructive sleep apnea.

Authors:  Giuseppe Insalaco; Salvatore Romano; Oreste Marrone; Adriana Salvaggio; Giovanni Bonsignore
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

8.  Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging.

Authors:  Richard J Schwab; Michael Pasirstein; Robert Pierson; Adonna Mackley; Robert Hachadoorian; Raanan Arens; Greg Maislin; Allan I Pack
Journal:  Am J Respir Crit Care Med       Date:  2003-05-13       Impact factor: 21.405

9.  Upper airway length may be associated with the severity of obstructive sleep apnea syndrome.

Authors:  Yosef Segal; Atul Malhotra; Giora Pillar
Journal:  Sleep Breath       Date:  2008-05-31       Impact factor: 2.816

10.  Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets.

Authors:  Danny J Eckert; David P White; Amy S Jordan; Atul Malhotra; Andrew Wellman
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

View more
  11 in total

1.  Influence of interface and position on upper airway collapsibility assessed by negative expiratory pressure.

Authors:  Raquel Pastrello Hirata; Fabiane Kayamori; Fabiola Schorr; Henrique Takachi Moriya; Salvatore Romano; Giuseppe Insalaco; Eloisa Gebrim; Luis Vicente Franco de Oliveira; Pedro Rodrigues Genta; Geraldo Lorenzi-Filho
Journal:  Sleep Breath       Date:  2017-01-07       Impact factor: 2.816

Review 2.  More Than the Sum of the Respiratory Events: Personalized Medicine Approaches for Obstructive Sleep Apnea.

Authors:  Bradley A Edwards; Susan Redline; Scott A Sands; Robert L Owens
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

3.  A Novel Model to Estimate Key Obstructive Sleep Apnea Endotypes from Standard Polysomnography and Clinical Data and Their Contribution to Obstructive Sleep Apnea Severity.

Authors:  Ritaban Dutta; Gary Delaney; Barbara Toson; Amy S Jordan; David P White; Andrew Wellman; Danny J Eckert
Journal:  Ann Am Thorac Soc       Date:  2021-04

4.  It's possible: why don't we do it?

Authors:  Winfried Randerath
Journal:  J Clin Sleep Med       Date:  2021-06-01       Impact factor: 4.324

Review 5.  Obstructive sleep apnea: focus on myofunctional therapy.

Authors:  Cláudia Maria de Felício; Franciele Voltarelli da Silva Dias; Luciana Vitaliano Voi Trawitzki
Journal:  Nat Sci Sleep       Date:  2018-09-06

6.  Effect of tube length on the buckling pressure of collapsible tubes.

Authors:  M Amin F Zarandi; Kevin Garman; John S Rhee; B Tucker Woodson; Guilherme J M Garcia
Journal:  Comput Biol Med       Date:  2021-07-28       Impact factor: 6.698

Review 7.  Obstructive sleep apnea: current perspectives.

Authors:  Amal M Osman; Sophie G Carter; Jayne C Carberry; Danny J Eckert
Journal:  Nat Sci Sleep       Date:  2018-01-23

Review 8.  Scientific production of Brazilian speech language pathologists in sleep medicine.

Authors:  Camila de Castro Corrêa; Fabiane Kayamori; Silke Anna Theresa Weber; Esther Mandelbaum Gonçalves Bianchini
Journal:  Sleep Sci       Date:  2018 May-Jun

Review 9.  Obstructive Sleep Apnea: Emerging Treatments Targeting the Genioglossus Muscle.

Authors:  Olga Mediano; Sofia Romero-Peralta; Pilar Resano; Irene Cano-Pumarega; Manuel Sánchez-de-la-Torre; María Castillo-García; Ana Belén Martínez-Sánchez; Ana Ortigado; Francisco García-Río
Journal:  J Clin Med       Date:  2019-10-22       Impact factor: 4.241

Review 10.  Critical to Know Pcrit: A Review on Pharyngeal Critical Closing Pressure in Obstructive Sleep Apnea.

Authors:  Elahe Kazemeini; Eli Van de Perck; Marijke Dieltjens; Marc Willemen; Johan Verbraecken; Sara Op de Beeck; Olivier M Vanderveken
Journal:  Front Neurol       Date:  2022-02-22       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.